World hepatitis day in Burkina Faso, 2017: seroprevalence and vaccination against hepatitis B virus to achieve the 2030 elimination goal

Birama Diarra,Albert Théophane Yonli,Abdoul Karim Ouattara,Théodora Mahoukèdè Zohoncon,Lassina Traore,Christelle Nadembega,Dorcas Obiri-Yeboah,Justine Yara,Virginio Pietra,Paul Ouedraogo,Bougouma A,Rokia Sanogo,Jacques Simpore

World hepatitis day in Burkina Faso, 2017: seroprevalence and vaccination against hepatitis B virus to achieve the 2030 elimination goal

2018

Birama Diarra
Albert Théophane Yonli
Abdoul Karim Ouattara
Théodora Mahoukèdè Zohoncon
Lassina Traore
Christelle Nadembega
Dorcas Obiri-Yeboah
Justine Yara
Virginio Pietra
Paul Ouedraogo
Bougouma A
Rokia Sanogo
Jacques Simpore

Background Burkina Faso is a high endemicity country for HBV infection. However, there are few data on vaccine coverage against HBV. The aim of this study was to contribute to the improvement of HBV vaccine coverage in Ouagadougou through HBV screening.

Keywords:

Hepatitis B
Disease Eradication
Virology
Seroprevalence
Biology
Seroepidemiologic Studies
Hepatitis B antibody
Hepatitis B virus
Vaccination
Hepatitis
Young adult
Environmental health
Ethics committee
HBsAg

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations